{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:49:31Z","timestamp":1762033771891,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.vaccine.2020.07.077","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T16:17:18Z","timestamp":1596989838000},"page":"6592-6599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Absence of YF-neutralizing antibodies in vulnerable populations of Brazil: A warning for epidemiological surveillance and the potential risks for future outbreaks"],"prefix":"10.1016","volume":"38","author":[{"given":"Ana Gabriella","family":"Stoffella-Dutra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaqueline","family":"Silva de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galileu","family":"Barbosa Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erna","family":"Geessien Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f4natas","family":"Santos Abrah\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelle","family":"Desiree LaBeaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bet\u00e2nia","family":"Paiva Drumond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Bretas de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giliane","family":"de Souza Trindade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.07.077_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.ento.52.110405.091454","article-title":"Yellow Fever: A Disease that Has Yet to be Conquered","volume":"52","author":"Barrett","year":"2007","journal-title":"The Annual Review of Entomology"},{"key":"10.1016\/j.vaccine.2020.07.077_b0010","unstructured":"Lindenbach, B.D, Murray CL, Thiel HJ, Rice CM. Flaviviridae. In: Knipe DM, Howley PM, editors. Fields Virol; 2013."},{"key":"10.1016\/j.vaccine.2020.07.077_b0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cll.2010.01.001","article-title":"Yellow Fever: A Reemerging Threat","volume":"30","author":"Gardner","year":"2010","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.vaccine.2020.07.077_b0020","unstructured":"Brasil. Febre Amarela. Guia para profissionais da sa\u00fade. Bras\u00edlia, DF. 1\u00aa edi\u00e7\u00e3o atualizada, 1\u00aa reimpress\u00e3o. Secretaria de aten\u00e7\u00e3o \u00e0 sa\u00fade, Minist\u00e9rio da Sa\u00fade, 2019."},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.077_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","article-title":"Yellow fever: an update","volume":"1","author":"Monath","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.07.077_b0030","unstructured":"WHO. Yellow fever, fact sheets. World Health Organization, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever; 2019. [accessed 07 november 2019]."},{"key":"10.1016\/j.vaccine.2020.07.077_b0035","doi-asserted-by":"crossref","unstructured":"Possas, C. et al. Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation. Mem Inst Oswaldo Cruz, Rio de Janeiro, 113(10): e180278, 2018. doi: 10.1590\/0074-02760180278.","DOI":"10.1590\/0074-02760180278"},{"issue":"11","key":"10.1016\/j.vaccine.2020.07.077_b0040","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.tim.2018.05.012","article-title":"Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe","volume":"26","author":"Douam","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2020.07.077_b0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"Use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med."},{"key":"10.1016\/j.vaccine.2020.07.077_b0050","first-page":"1942","article-title":"Yellow Fever in the Americas, 1938\u20131942","volume":"a","author":"Soper","year":"1938","journal-title":"Febre Amarela Panam."},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.077_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-019-1277-7","article-title":"Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease","volume":"17","author":"Silva","year":"2020","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2020.07.077_b0060","unstructured":"Minist\u00e9rio Da Sa\u00fade. Monitoramento de Febre Amarela, Brasil, 2019. Informe n\u00b0 18, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Minist\u00e9rio da Sa\u00fade. CGDT\/DEVIT\/SVS\/MS. Atualiza\u00e7\u00e3o 04\/06\/2019. https:\/\/www.saude.gov.br\/images\/pdf\/2019\/junho\/13\/Informe-de-Monitoramento-de-Febre-Amarela-Brasil--n-18.pdf [accessed 06 march 2020]."},{"key":"10.1016\/j.vaccine.2020.07.077_b0065","unstructured":"Minist\u00e9rio Da Sa\u00fade. Monitoramento do per\u00edodo sazonal da febre amarela Brasil, 2017\/2018. Informe n\u00b0 27, Minist\u00e9rio da Sa\u00fade. CGDT\/DEVIT\/SVS\/MS. https:\/\/www.saude.gov.br\/images\/pdf\/2018\/outubro\/08\/Informe-FA.pdf, 04\/10\/2018, [accessed 06 march 2020]."},{"key":"10.1016\/j.vaccine.2020.07.077_b0070","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s10393-018-1364-z","article-title":"Detection and Molecular Characterization of Yellow Fever Virus, 2017, Brazil","volume":"15","author":"Figueiredo","year":"2018","journal-title":"EcoHealth"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.077_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5123\/S1679-49742011000100011","article-title":"Yellow Fever in Brazil: Recommendations for Surveillance, Prevention and Control","volume":"20","author":"Romano","year":"2011","journal-title":"Epidemiol. Serv. Sa\u00fade, Bras\u00edlia"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.077_b0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/hs.2017.0004","article-title":"What We Are Watching\u2014Top Global Infectious Disease Threats, 2013-2016: An Update from CDC's Global Disease Detection Operations Center","volume":"15","author":"Christian","year":"2017","journal-title":"Health Security"},{"key":"10.1016\/j.vaccine.2020.07.077_b0085","unstructured":"WHO. A Global Strategy to Eliminate Yellow Fever Epidemics (EYE) 2017-2026. World Health Organization, version 1,august, 2017."},{"key":"10.1016\/j.vaccine.2020.07.077_b0090","unstructured":"IBGE. Censo demogr\u00e1fico 2010. Instituto Brasileiro de Geografia e Estat\u00edstica, https:\/\/cidades.ibge.gov.br\/brasil\/mg\/serro\/pesquisa\/23\/25207?indicador=25199; 2010 [accessed 04 november 2019]."},{"key":"10.1016\/j.vaccine.2020.07.077_b0095","unstructured":"COSTA, Z.G.A. Estudo das caracter\u00edsticas epidemiol\u00f3gicas da Febre Amarela no Brasil, nas \u00e1reas fora da amaz\u00f4nia legal, no per\u00edodo de 1999 a 2003. Escola Nacional de Sa\u00fade P\u00fablica Sergio Arouca, Bras\u00edlia, Distrito Federal, 2005."},{"key":"10.1016\/j.vaccine.2020.07.077_b0100","unstructured":"SVS. Epidemia de febre amarela silvestre na regi\u00e3o da bacia do rio doce \u2013 minas gerais. Dezembro de 2002 a mar\u00e7o de 2003. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Boletim Eletr\u00f4nico Epidemiol\u00f3gico. Ano 03 - n\u00b0 06, 2003."},{"key":"10.1016\/j.vaccine.2020.07.077_b0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10393-018-1353-2","article-title":"Silent Orthohantavirus Circulation Among Humans and Small Mammals from Central Minas Gerais, Brazil","volume":"15","author":"Amaral","year":"2018","journal-title":"EcoHealth"},{"issue":"121","key":"10.1016\/j.vaccine.2020.07.077_b0110","article-title":"Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV","volume":"13","author":"Costa","year":"2016","journal-title":"Virology Journal"},{"key":"10.1016\/j.vaccine.2020.07.077_b0115","unstructured":"WHO. Guidelines for plaque reduction neutralization testing of human antibodies to dengue viruses. World Health Organization. Department of Immunization, Vaccines and Biologicals, 2007."},{"key":"10.1016\/j.vaccine.2020.07.077_b0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tvjl.2012.08.019","article-title":"Review of diagnostic plaque reduction neutralization tests for flavivirus infection","volume":"195","author":"Maeda","year":"2013","journal-title":"Vet J"},{"issue":"129","key":"10.1016\/j.vaccine.2020.07.077_b0125","article-title":"Yellow fever in the diagnostics laboratory","volume":"7","author":"Domingo","year":"2018","journal-title":"Emerging Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.07.077_b0130","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3390\/v11111029","article-title":"Silent Circulation of the Saint Louis Encephalitis Virus among Humans and Equids, Southeast Brazil","volume":"11","author":"Barbosa Costa","year":"2019","journal-title":"Viruses"},{"issue":"6405","key":"10.1016\/j.vaccine.2020.07.077_b0135","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1126\/science.aat7115","article-title":"Genomic and epidemiological monitoring of yellow fever virus transmission potential","volume":"361","author":"Faria","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.077_b0140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1590\/S0037-86822009000500009","article-title":"Febre amarela: estudo de um surto","volume":"42","author":"Ribeiro","year":"2009","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.vaccine.2020.07.077_b0145","unstructured":"SES\/MG. Informe Epidemiol\u00f3gico da Febre Amarela. Febre Amarela Silvestre em Minas Gerais (19\/02). Secretaria do Estado de Sa\u00fade de Minas Gerais, Subsecretaria de Vigil\u00e2ncia e Prote\u00e7\u00e3o \u00e0 Sa\u00fade, http:\/\/www.saude.mg.gov.br\/images\/noticias_e_eventos\/000_2019\/jane_fev_mar\/Febre_Amarela\/Boletim_atualiza%C3%A7%C3%A3o_FA_12-02-2019.pdf; 2019. [accessed 06 march 2020]."},{"key":"10.1016\/j.vaccine.2020.07.077_b0150","unstructured":"SES\/MG. Dados de Cobertura Vacinal em Minas Gerais. Secretaria de Estado de Sa\u00fade de Minas Gerais. Atualiza\u00e7\u00e3o em 13\/02\/2019. http:\/\/www.saude.mg.gov.br\/febreamarela, 2019. [accessed 06 march 2020]."},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.077_b0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S0037-86822003000200012","article-title":"Febre amarela","volume":"36","author":"Vasconcelos","year":"2003","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.vaccine.2020.07.077_b0160","unstructured":"WHO. World health organization. Yellow fever: International travel and health, https:\/\/www.who.int\/ith\/diseases\/yf\/en\/; 2020. [accessed 28 february 2020]."},{"key":"10.1016\/j.vaccine.2020.07.077_b0165","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2018.1406800","article-title":"The 17D\u2013204 and 17DD yellow fever vaccines: an overview of major similarities and subtle diferences","author":"Ferreira","year":"2018","journal-title":"Expert review of vacines"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.077_b0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/jir439","article-title":"Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody","volume":"204","author":"Luiza-Silva","year":"2011","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2020.07.077_b0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41541-020-0205-6","article-title":"Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection","volume":"5","author":"Staples","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2020.07.077_b0180","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1172\/JCI75429","article-title":"Immune activation alters cellular and humoral responses to yellow fever 17D vaccine","volume":"124","author":"Muyanja","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.vaccine.2020.07.077_b0185","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946201759002","article-title":"Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults","volume":"59","author":"Miyaji","year":"2017","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"key":"10.1016\/j.vaccine.2020.07.077_b0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trstmh.2006.04.001","article-title":"Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998\u20132002","volume":"101","author":"Tuboi","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.077_b0195","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00084-18","article-title":"Factors That Influence the Immune Response to Vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Reviews"},{"issue":"8","key":"10.1016\/j.vaccine.2020.07.077_b0200","doi-asserted-by":"crossref","DOI":"10.3201\/eid2508.181432","article-title":"17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil","volume":"25","author":"Campi-Azevedo","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.07.077_b0205","unstructured":"WHO. Weekly epidemiological record. Vaccines and vaccination against yellow fever. World Health Organization, Position Paper \u2013 June 2013. No. 27, 2013, 88, 269\u2013284. https:\/\/www.who.int\/wer\/2013\/wer8827.pdf?ua=1. [accessed 28 february 2020]."},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.077_b0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1590\/0074-02760170347","article-title":"Single shot of 17D vaccine may not confer life-long protection against yellow fever","volume":"113","author":"Vasconcelos","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.077_b0215","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bjm.2018.02.003","article-title":"Is a dose of 17D vaccine in the current context of Yellow Fever enough?","volume":"49","author":"Estofolete","year":"2018","journal-title":"Brazilian Journal of Microbiology. Jul-Sep"},{"key":"10.1016\/j.vaccine.2020.07.077_b0220","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1016\/j.vaccine.2014.07.021","article-title":"Duration of post-vaccination immunity against yellow fever in adults","volume":"32","author":"Caldas","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.077_b0225","doi-asserted-by":"crossref","first-page":"491 502","DOI":"10.1080\/21645515.2015.1082693","article-title":"Booster dose after 10 years is recommended following 17DD-YF primary vaccination","volume":"12","author":"Campi-Azevedo","year":"2016","journal-title":"Human Vaccines & Immunotherapeutics."},{"key":"10.1016\/j.vaccine.2020.07.077_b0230","unstructured":"IBF. Bioma Mata Atl\u00e2ntica. Instituto Brasileiro de Florestas, https:\/\/www.ibflorestas.org.br\/bioma-mata-atlantica.html; 2018. [accessed 06 march 2020]."},{"key":"10.1016\/j.vaccine.2020.07.077_b0235","unstructured":"LIRAa. Levantamento de \u00cdndice R\u00e1pido para Aedes aegypti (LIRAa). SES-MG, Secretaria de Estado de Sa\u00fade de Minas Gerais, janeiro de 2019, http:\/\/www.saude.mg.gov.br\/aedes [accessed 09 march 2020]."},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.077_b0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/0037-8682-0007-2012","article-title":"Serologic assessment of yellow fever immunity in the rural population of a yellow fever-endemic area in Central Brazil","volume":"46","author":"Machado","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"issue":"35","key":"10.1016\/j.vaccine.2020.07.077_b0245","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2016.06.053","article-title":"Monitoring vaccination coverage: Defining the role of surveys","volume":"34","author":"Cutts","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.07.077_b0250","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1016\/j.vaccine.2016.06.002","article-title":"A 16-year review of seroprevalence studies on measles and rubella","volume":"34","author":"Dimech","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.077_b0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/v9040077","article-title":"T Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal Models","volume":"9","author":"Watson","year":"2017","journal-title":"Viruses."},{"key":"10.1016\/j.vaccine.2020.07.077_b0260","first-page":"UFVJM","article-title":"Dengue na regi\u00e3o do Alto do Jequitinhonha: an\u00e1lise das notifica\u00e7\u00f5es. Revista Vozes dos Vales: Publica\u00e7\u00f5es Acad\u00eamicas","volume":"120.2.095","author":"Moura","year":"2016","journal-title":"Universidade Federal dos Vales do Jequitinhonha e Mucuri, Reg."},{"key":"10.1016\/j.vaccine.2020.07.077_b0265","unstructured":"SES\/MG. Boletim epidemiol\u00f3gico de monitoramento dos casos de Dengue, Chikungunya e Zika, n\u00b0 116. Secretaria de Estado de Sa\u00fade de Minas Gerais, SES\/MG https:\/\/www.saude.mg.gov.br\/images\/documentos\/Boletim_Aedes_11-12-2018_AREA_TECNICA.pdf, 10\/12\/2018 [accessed 09 march 2020]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:27Z","timestamp":1759402047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20310252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":53,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0264410X20310252"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absence of YF-neutralizing antibodies in vulnerable populations of Brazil: A warning for epidemiological surveillance and the potential risks for future outbreaks","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}